This article investigates potential issues for anti-trust policy regarding e-pharmacies. These entities have gained prominence in many countries due to the ongoing COVID-19 pandemic and seem to provide an alternative channel for consumers. However, the extent to which the promise of an added dimension of competition in the retailing of medicines is made possible by